TLPH
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-06-22–present
Board Member
Talphera, Inc. (TLPH)Equibles does not estimate personal net worth.
Get an email with a short summary when Talphera, Inc. publishes a filing, an earnings call transcript or a press release.
Get TLPH alertsMarina Bozilenko is recorded as Board Member at Talphera, Inc. (TLPH) since June 22, 2026. Talphera, Inc. reported in an 8-K filed June 23, 2026 that Marina Bozilenko was appointed Class III director, effective June 22, 2026. Talphera, Inc. reported in an 8-K filed October 10, 2023 that Marina Bozilenko was appointed Class III director, effective October 10, 2023. Talphera, Inc. reported in an 8-K filed March 31, 2021 that Marina Bozilenko was appointed Class III director of the Board, effective March 30, 2021. Talphera, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Talphera, Inc. includes Vincent J. Angotti (CEO and Board Member), Raffi Asadorian (CFO), Abhinav Jain (Board Member) and 7 others.
“Marina Bozilenko, Joseph Todisco and Mark Wan were elected as Class III directors, by a plurality of the votes entitled to vote on the election of directors, to hold office until the 2029 Annual Meeting of Stockholders by the following vote:”
“Marina Bozilenko, Howard B. Rosen and Mark Wan were elected as Class III directors, by a plurality of the votes entitled to vote on the election of directors, to hold office until the 2026 Annual Meeting of Stockholders by the following vote:”
2026-06-22–present
TLPH
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2026-06-22–present